business / news / / Devdiscourse
The FDA has blocked the publication of studies regarding the safety of COVID-19 and shingles vaccines.
The FDA has blocked the publication of studies on COVID-19 and shingles vaccine safety.
KEY POINTS
- The FDA approved fruit-flavored e-cigarettes by Glas Inc., the first non-tobacco flavor authorization.
- Novo Nordisk outperformed profit forecasts due to strong demand for its new weight-loss pill.
- Gilead Sciences' HIV injection Yeztugo faces obstacles from insurance gaps and cost-sharing issues.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →